Aristolochic acid-induced apoptosis and G2 cell cycle arrest depends on ROS generation and MAP kinases activation

Archives of Toxicology

Volumn 89, Issue 1, 2015, Pages 47-56

  Romanov, Victor ^a   Whyard, Terry C ^a   Waltzer, Wayne C ^a   Grollman, Arthur P ^a   Rosenquist, Thomas ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Apoptosis; Aristolochic acid; G2 M DNA damage checkpoint; MAP kinases; Signal transduction

Indexed keywords

ACETYLCYSTEINE; ARISTOLOCHIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; SYNAPTOPHYSIN; ARISTOLOCHIC ACID I; MITOGEN ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL DEATH; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA DAMAGE CHECKPOINT; ENZYME ACTIVATION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; KIDNEY EPITHELIUM; PRIORITY JOURNAL; CELL LINE; DNA DAMAGE; DOSE RESPONSE; DRUG EFFECTS; EPITHELIUM CELL; KIDNEY PROXIMAL TUBULE; METABOLISM; PATHOLOGY;

APOPTOSIS; ARISTOLOCHIC ACIDS; CELL LINE; CELL SURVIVAL; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; KIDNEY TUBULES, PROXIMAL; REACTIVE OXYGEN SPECIES;

EID: 84940732505     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-014-1249-z     Document Type: Article

References (42)

1. Ambrosino C, Nebreda AR (2001) Cell cycle regulation by p38 MAP kinases. Biol Cell 93(1–2):47–51
2. Andorfer P, Schwarzmayr L, Rotheneder H (2011) EAPP modulates the activity of p21 and Chk2. Cell Cycle 10(13):2077–2082
3. Arlt VM, Pfohl-Leszkowicz A, Cosyns J, Schmeiser HH (2001) Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutat Res 494(1–2):143–150
4. Attaluri S, Bonala RR, Yang IY, Lukin MA, Wen Y, Grollman AP, Moriya M, Iden CR, Johnson F (2010) DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells. Nucleic Acids Res 38(1):339–352
5. Bieler CA, Stiborova M, Wiessler M, Cosyns JP, Ypersele van de Strihou C, Schmeiser HH (1997) 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenesis 18(5):1063–1067
6. Chambard JC, Lefloch R, Pouyssegur J, Lenormand P (2007) ERK implication in cell cycle regulation. Biochim Biophys Acta 1773(8):1299–1310
7. Chang HR, Lian JD, Lo CW, Chang YC, Yang MY, Wang CJ (2006) Induction of urothelial proliferation in rats by aristolochic acid through cell cycle progression via activation of cyclin D1/cdk4 and cyclin E/cdk2. Food Chem Toxicol 44(1):28–35
8. Chang HR, Lian JD, Lo CW, Huang HP, Wang CJ (2007) Aristolochic acid-induced cell cycle G1 arrest in human urothelium SV-HUC-1 cells. Food Chem Toxicol 45(3):396–402
9. Chen YY, Chiang SY, Wu HC, Kao ST, Hsiang CY, Ho TY, Lin JG (2010) Microarray analysis reveals the inhibition of nuclear factor-kappa B signaling by aristolochic acid in normal human kidney (HK-2) cells. Acta Pharmacol Sin 31(2):227–236
10. Chen M, Gong L, Qi X, Xing G, Luan Y, Wu Y, Xiao Y, Yao J, Li Y, Xue X, Pan G, Ren J (2011) Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity. Toxicol Sci 122(2):288–296
11. Correia I, Alonso-Monge R, Pla J (2010) MAPK cell-cycle regulation in Saccharomyces cerevisiae and Candida albicans. Future Microbiol 5(7):1125–1141
12. Gao R, Zheng F, Liu Y, Zheng D, Li X, Bo Y, Liu Y (2000) Aristolochic acid I-induced apoptosis in LLC-PK1 cells and amelioration of the apoptotic damage by calcium antagonist. Chin Med J (Engl) 113(5):418–424
13. Gaul L, Mandl-Weber S, Baumann P, Emmerich B, Schmidmaier R (2008) Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM–Chk2–Cdc25A and ATM–p53–p21-pathways. J Cancer Res Clin Oncol 134(2):245–253
14. Jiang Z, Bao Q, Sun L, Huang X, Wang T, Zhang S, Li H, Zhang L (2013) Possible role of mtDNA depletion and respiratory chain defects in aristolochic acid I-induced acute nephrotoxicity. Toxicol Appl Pharmacol 266(2):198–203
15. Kwak DH, Lee JH, Kim T, Ahn HS, Cho WK, Ha H, Hwang YH, Ma JY (2012) Aristolochia Manshuriensis Kom inhibits adipocyte differentiation by regulation of ERK1/2 and Akt pathway. PLoS One 7(11):e49530
16. Li Y, Liu Z, Guo X, Shu J, Chen Z, Li L (2006) Aristolochic acid I-induced DNA damage and cell cycle arrest in renal tubular epithelial cells in vitro. Arch Toxicol 80(8):524–532
17. Liu Q, Wang Q, Yang X, Shen X, Zhang B (2009) Differential cytotoxic effects of denitroaristolochic acid II and aristolochic acids on renal epithelial cells. Toxicol Lett 184(1):5–12
18. Nitzsche D, Melzig MF, Arlt VM (2013) Evaluation of the cytotoxicity and genotoxicity of aristolochic acid I—a component of Aristolochiaceae plant extracts used in homeopathy. Environ Toxicol Pharmacol 35(2):325–334
19. Page K, Hershenson MB (2000) Mitogen-activated signaling and cell cycle regulation in airway smooth muscle. Front Biosci 5:D258–D267
20. Pozdzik AA, Salmon IJ, Debelle FD, Decaestecker C, Van den Branden C, Verbeelen D, Deschodt-Lanckman MM, Vanherweghem JL, Nortier JL (2008) Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int 73(5):595–607
21. Qi X, Cai Y, Gong L, Liu L, Chen F, Xiao Y, Wu X, Li Y, Xue X, Ren J (2007) Role of mitochondrial permeability transition in human renal tubular epithelial cell death induced by aristolochic acid. Toxicol Appl Pharmacol 222(1):105–110
22. Rodriguez-Garcia ME, Quiroga AG, Castro J, Ortiz A, Aller P, Mata F (2009) Inhibition of p38-MAPK potentiates cisplatin-induced apoptosis via GSH depletion and increases intracellular drug accumulation in growth-arrested kidney tubular epithelial cells. Toxicol Sci 111(2):413–423
23. Romanov V, Whyard T, Bonala R, Johnson F, Grollman A (2011) Glutamate dehydrogenase requirement for apoptosis induced by aristolochic acid in renal tubular epithelial cells. Apoptosis 16(12):1217–1228
24. Rui HL, Wang YY, Cheng H, Chen YP (2012) JNK-dependent AP-1 activation is required for aristolochic acid-induced TGF-beta1 synthesis in human renal proximal epithelial cells. Am J Physiol Renal Physiol 302(12):F1569–F1575
25. Schmeiser HH, Schoepe KB, Wiessler M (1988) DNA adduct formation of aristolochic acid I and II in vitro and in vivo. Carcinogenesis 9(2):297–303
26. Schmeiser HH, Scherf HR, Wiessler M (1991) Activating mutations at codon 61 of the c-Ha-ras gene in thin-tissue sections of tumors induced by aristolochic acid in rats and mice. Cancer Lett 59(2):139–143
27. Shen MY, Liu CL, Hsiao G, Liu CY, Lin KH, Chou DS, Sheu JR (2008) Involvement of p38 MAPK phosphorylation and nitrate formation in aristolochic acid-mediated antiplatelet activity. Planta Med 74(10):1240–1245
28. Shi H, Feng JM (2011) Aristolochic acid induces apoptosis of human umbilical vein endothelial cells in vitro by suppressing PI3K/Akt signaling pathway. Acta Pharmacol Sin 32(8):1025–1030
29. Shibutani S, Dong H, Suzuki N, Ueda S, Miller F, Grollman AP (2007) Selective toxicity of aristolochic acids I and II. Drug Metab Dispos 35(7):1217–1222
30. Stark GR, Taylor WR (2004) Analyzing the G2/M checkpoint. Methods Mol Biol 280:51–82
31. Stiborova M, Frei E, Schmeiser HH (2008a) Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid. Kidney Int 73(11):1209–1211
32. Stiborova M, Hudecek J, Frei E, Schmeiser HH (2008b) Contribution of biotransformation enzymes to the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions, difficult answers. Interdiscip Toxicol 1(1):8–12
33. Stiborova M, Frei E, Arlt VM, Schmeiser HH (2009) The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 153(1):5–11
34. Stiborova M, Levova K, Barta F, Shi Z, Frei E, Schmeiser HH, Nebert DW, Phillips DH, Arlt VM (2012) Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2. Toxicol Sci 125(2):345–358
35. Tentner AR, Lee MJ, Ostheimer GJ, Samson LD, Lauffenburger DA, Yaffe MB (2012) Combined experimental and computational analysis of DNA damage signaling reveals context-dependent roles for Erk in apoptosis and G1/S arrest after genotoxic stress. Mol Syst Biol 8:568
36. Xiao Y, Ge M, Xue X, Wang C, Wang H, Wu X, Li L, Liu L, Qi X, Zhang Y, Li Y, Luo H, Xie T, Gu J, Ren J (2008) Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity. Kidney Int 73(11):1231–1239
37. Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV (2010) Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16(5):535–543, 531 p following 143
38. Yang H, Dou Y, Zheng X, Tan Y, Cheng J, Li L, Du Y, Zhu D, Lou Y (2011) Cysteinyl leukotrienes synthesis is involved in aristolochic acid I-induced apoptosis in renal proximal tubular epithelial cells. Toxicology 287(1–3):38–45
39. Yu FY, Wu TS, Chen TW, Liu BH (2011) Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1/2 activation in human cells. Toxicol In Vitro 25(4):810–816
40. Zeng Y, Yang X, Wang J, Fan J, Kong Q, Yu X (2012) Aristolochic acid I induced autophagy extenuates cell apoptosis via ERK 1/2 pathway in renal tubular epithelial cells. PLoS One 7(1):e30312
41. Zhou L, Fu P, Huang XR, Liu F, Lai KN, Lan HY (2010) Activation of p53 promotes renal injury in acute aristolochic acid nephropathy. J Am Soc Nephrol 21(1):31–41
42. Zhu S, Wang Y, Jin J, Guan C, Li M, Xi C, Ouyang Z, Chen M, Qiu Y, Huang M, Huang Z (2012) Endoplasmic reticulum stress mediates aristolochic acid I-induced apoptosis in human renal proximal tubular epithelial cells. Toxicol In Vitro 26(5):663–671